| Ajanta Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532331 |
NSE Symbol : AJANTPHARM |
P/E(TTM) : 40.42 |
|
ISIN Demat : INE031B01049 |
Div & Yield% : 0.92 |
EPS(TTM) : 75.78 |
|
Book Value(₹) : 338.05 |
Market Cap(₹Cr) : 38,263.41 |
Face Value(₹) : 2.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 1,210.53 | 1,206.59 | 1,220.24 | 1,208.56 | 1,013.94 | 1,101.92 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,210.53 | 1,206.59 | 1,220.24 | 1,208.56 | 1,013.94 | 1,101.92 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 62.98 | 25.76 | 75.03 | 40.63 | 17.93 | 33.23 |
| Total Income | 1,273.51 | 1,232.35 | 1,295.27 | 1,249.19 | 1,031.87 | 1,135.15 |
| Total Expenditure | 972.48 | 865.64 | 930.65 | 879.16 | 764.29 | 765.59 |
| PBIDT | 301.03 | 366.71 | 364.62 | 370.03 | 267.58 | 369.56 |
| Interest | -0.74 | 1.87 | 0.73 | 0.73 | 0.67 | 2.48 |
| PBDT | 301.77 | 364.84 | 363.89 | 369.30 | 266.91 | 367.08 |
| Depreciation | 44.16 | 42.38 | 41.92 | 40.31 | 38.76 | 34.93 |
| Tax | 67.33 | 72.58 | 65.97 | 70.73 | 39.10 | 76.38 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -7.00 | 4.84 | 6.47 | 3.29 | -4.38 | 3.32 |
| Reported Profit After Tax | 197.28 | 245.04 | 249.53 | 254.97 | 193.43 | 252.45 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 197.28 | 245.04 | 249.53 | 254.97 | 193.43 | 252.45 |
| EPS (Unit Curr.) | 15.79 | 19.61 | 19.98 | 20.41 | 15.46 | 20.16 |
| EPS (Adj) (Unit Curr.) | 15.79 | 19.61 | 19.98 | 20.41 | 15.46 | 20.16 |
| Calculated EPS (Unit Curr.) | 15.74 | 19.55 | 19.91 | 20.34 | 15.43 | 20.14 |
| Calculated EPS (Adj) (Unit Curr.) | 15.74 | 19.55 | 19.91 | 20.34 | 15.43 | 20.14 |
| Calculated EPS (Ann.) (Unit Curr.) | 62.95 | 78.19 | 79.63 | 81.36 | 61.72 | 80.56 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 62.95 | 78.19 | 79.63 | 81.36 | 61.72 | 80.56 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 25.07 | 25.07 | 25.07 | 25.07 | 25.07 | 25.07 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 24.87 | 30.39 | 29.88 | 30.62 | 26.39 | 33.54 |
| PBDTM(%) | 24.93 | 30.24 | 29.82 | 30.56 | 26.32 | 33.31 |
| PATM(%) | 16.30 | 20.31 | 20.45 | 21.10 | 19.08 | 22.91 |
